ERBB2 retargeted viruses have been extensively characterized for the specific tropism for ERBB2 positive tumours14,15; fully virulent oHSV with restricted tropism to ERBB2 expressing tumours proved to be efficacious in preclinical models26. The gene discussed is ERBB2; the disease is neoplasm.